Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19.7M
-
Number of holders
-
213
-
Total 13F shares, excl. options
-
21.6M
-
Shares change
-
-846K
-
Total reported value, excl. options
-
$2.18B
-
Value change
-
-$68.4M
-
Put/Call ratio
-
0.32
-
Number of buys
-
106
-
Number of sells
-
-110
-
Price
-
$100.90
Significant Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q2 2015
239 filings reported holding LGND - LIGAND PHARMACEUTICALS INC - Common Stock as of Q2 2015.
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) has 213 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.6M shares
.
Largest 10 shareholders include BLAIR WILLIAM & CO/IL (1.47M shares), VANGUARD GROUP INC (1.31M shares), BlackRock Fund Advisors (1.28M shares), Knott David M (1.25M shares), FMR LLC (1.02M shares), CARDINAL CAPITAL MANAGEMENT LLC /CT (1.01M shares), RS INVESTMENT MANAGEMENT CO LLC (983K shares), Invesco Ltd. (947K shares), Bank of New York Mellon Corp (607K shares), and STATE STREET CORP (605K shares).
This table shows the top 213 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.